Standard Biotools (LAB) Other Accumulated Expenses (2022 - 2026)

Standard Biotools (LAB) has 5 years of Other Accumulated Expenses data on file, last reported at $1.5 million in Q1 2026.

• Quarterly Other Accumulated Expenses fell 66.99% year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (down 66.99% YoY) and the FY2025 annual result came in at $1.5 million, down 68.85% from the prior year.
• Other Accumulated Expenses improved to $1.5 million in Q1 2026 per LAB's latest filing, from $1.5 million in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $7.3 million in Q3 2024 and bottomed at $714000.0 in Q3 2023.
• The 5-year median for Other Accumulated Expenses is $3.3 million (2023), against an average of $3.5 million.
• The widest annual swing landed in 2024, when Other Accumulated Expenses jumped 917.51%; it then slumped 83.63% in 2025.
• Tracing LAB's Other Accumulated Expenses over 5 years: stood at $913000.0 in 2022, then soared by 341.73% to $4.0 million in 2023, then advanced by 15.5% to $4.7 million in 2024, then plunged by 68.85% to $1.5 million in 2025, then increased by 5.79% to $1.5 million in 2026.
• Per Business Quant, the three latest LAB Other Accumulated Expenses figures stand at $1.5 million (Q1 2026), $1.5 million (Q4 2025), and $2.5 million (Q3 2025).

Peer Comparison